Abstract
Although current guidelines support the use of EET in patients with Barrett’s esophagus (BE)-related neoplasia, quality indicators (QIs) for performing EET are lacking. With the healthcare shift from volume-based to value-based practice, there has been an increased emphasis to develop QIs that are evidence based, reliable and feasible.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
